Live Breaking News & Updates on விழித்திரை வலைப்பின்னல்

Stay updated with breaking news from விழித்திரை வலைப்பின்னல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Curbside Consults on Retinal Vein Occlusion Management


Curbside Consults on Retinal Vein Occlusion Management
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
1.00
CME
60
MINS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Subscribe
ADDED TO EMAIL ALERTS
You ve successfully added to your alerts. You will receive an email when new content is published.
Back to Healio
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Back to Healio
Support Statement
Activity Description ....

United States , Sankt Peterburg , University Of South Florida , Baylor College Of Medicine , Thomas Jefferson University , Ronalda Codario , Christinay Weng , Iveric Bio , David Eichenbaum , Allergan Abbvie , Carld Regillo , Network Eye , Boston Image Reading Center , Morsani College Of Medicine , Wills Eye Retina Service , Accreditation Council For Continuing Medical Education , Retina Vitreous Associates Of Florida , Regeneron Pharmaceuticals Inc , Drug Administration , Retina Network , Fellowship Program , Office Of Medical Affairs , Speakers Bureau , Wills Eye Retina , Vitreous Associates , Program Director ,

Surgical and drug treatment approaches are equally effective for diabetic eye disease


Surgical and drug treatment approaches are equally effective for diabetic eye disease
Surgical and injectable drug approaches are equally effective for treatment of bleeding inside the eye from proliferative diabetic retinopathy (PDR), according to a National Eye Institute (NEI)-supported clinical study from the DRCR Retina Network (DRCR.net). A consequence of diabetes, PDR involves the growth of new, abnormal blood vessels in the light-sensing retina. These blood vessels are prone to bleeding into the gel-like vitreous that fills the eye, causing vision loss. NEI is part of the National Institutes of Health.
Researchers compared anti-vascular endothelial growth factor (VEGF) eye injections versus removal of blood via vitrectomy surgery and laser photocoagulation. Both treatments improved central vision for the majority of participants, although approximately one-third of the participants needed both anti-VEGF injections and surgery. The findings will help guide treatment ....

United Kingdom , United States , Harvard University , Jennifer Sun , Adam Glassman , Emily Henderson , National Institute Of Diabetes , National Institutes Of Health , Diabetes Initiatives For The Network , Journal Of The American Medical Association , Retinal Network , Jaeb Center , Retina Network , National Eye Institute , Health Research , National Institutes , American Medical , Diabetes Initiatives , National Institute , Kidney Diseases , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , ஹார்வர்ட் பல்கலைக்கழகம் , ஜெனிபர் சூரியன் , பண்படாமனித இயல்பு கண்ணாடி மனிதன் , எமிலி ஹென்டர்சன் ,

Surgical and drug treatment options lead to similar outcomes for diabetic eye disease


Credit: Andrew Antoszyk, M.D.
Surgical and injectable drug approaches are equally effective for treatment of bleeding inside the eye from proliferative diabetic retinopathy (PDR), according to a National Eye Institute (NEI)-supported clinical study from the DRCR Retina Network (DRCR.net). A consequence of diabetes, PDR involves the growth of new, abnormal blood vessels in the light-sensing retina. These blood vessels are prone to bleeding into the gel-like vitreous that fills the eye, causing vision loss. NEI is part of the National Institutes of Health.
Researchers compared anti-vascular endothelial growth factor (VEGF) eye injections versus removal of blood via vitrectomy surgery and laser photocoagulation. Both treatments improved central vision for the majority of participants, although approximately one-third of the participants needed both anti-VEGF injections and surgery. The findings will help guide treatment for people with bleeding in the eye from PDR. The result ....

United Kingdom , United States , Harvard University , Jennifer Sun , Adam Glassman , National Institute Of Diabetes , Us Department Of Health , Human Services , National Institutes Of Health , Diabetes Initiatives For The Network , Retinal Network , Journal Of The American Medical Association , Diabetic Retinopathy Clinical Research Network , Jaeb Center , Retina Network , National Eye Institute , Health Research , National Institutes , American Medical , Diabetes Initiatives , National Institute , Kidney Diseases , Diabetic Retinopathy Clinical Research , Intravitreous Aflibercept Versus Vitrectomy , Panretinal Photocoagulation , Visual Acuity ,